Navigation Links
NDIS Approval of Promega PowerPlex® Fusion System Assists Laboratories in Meeting Evolving Standards

Madison, WI (PRWEB) March 22, 2013

Promega Corporation’s PowerPlex® Fusion System is now approved for use in laboratories that generate DNA records for the National DNA Index System (NDIS). NDIS is the U.S. national database containing over ten million offender profiles used to help authorities in solving criminal investigations nationwide, using the FBI’s CODIS system. This approval of PowerPlex Fusion follows the recent NDIS approval of PowerPlex® Y23 announced in January.

Launched in September 2012, the PowerPlex Fusion System is a 24-locus multiplex that incorporates common and informative loci used throughout the world. The PowerPlex Fusion System enables increased data sharing and greater discriminatory power than seen with previously available STR systems. The superior performance of the system, combined with its compatibility with existing allele-calling software and instrumentation, will enable laboratories to obtain more meaningful analyses without the need to invest time and funds into upgrading complex software or purchasing a new instrument.

Streamlined protocols are provided for amplifying extracted DNA, as well as DNA from sample types used for database and paternity testing. Cycling times of less than 90 minutes and reduced sample preparation times significantly shorten the total time needed to process samples, allowing laboratories to focus on more value-added activities.

"Our evaluation of the PowerPlex Fusion System and involvement in its developmental validation allowed us to directly confirm the value of this multiplex for forensic sample analysis”, said Jeffrey Nye of the Michigan State Police Forensic Science Division, the sponsoring laboratory for NDIS approval submission for PowerPlex Fusion. “NDIS approval will mean that laboratories can use this assay today to meet current standards and have the additional markers already in place for future database expansion."

The PowerPlex Fusion System offers rapid, more accurate results for forensic casework, offender databasing and paternity testing cases. To learn more, visit:

PowerPlex is a registered trademark of Promega Corporation.

About Promega
Promega Corporation is a leader in providing innovative solutions and technical support to the life sciences industry. The company’s 2,500 products enable scientists worldwide to advance their knowledge in genomics, proteomics, cellular analysis, molecular diagnostics and human identification. Founded in 1978, the company is headquartered in Madison, WI, USA with branches in 15 countries and over 50 global distributors. For more information about Promega, visit


Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Bayer CropScience and Syngenta Submit Herbicide-tolerance Soybean Trait for Approval in Various Countries
2. Hyperion Wins NDA Approval for UCD Drug Developed With Support from PharmaDirections
3. Todays Research on Incyte and Arena Pharma: Biotech Stocks Up on Drug Approvals
4. OsteoFab™ Patient Specific Cranial Device Receives 510(k) Approval
5. NDIS Approval of the Promega PowerPlex(R) Y23 System Enables More Usable Profiles in Less Time
6. California Biomedical Companies Report Higher Product Approvals, Fewer Delays
7. CfPIE’s Newest Training Course Facilitates Life Science Professionals in Staying Current with FDA Approval Trends
8. Syngenta Secures EU Approval For Next Generation Fungicide
9. C8 MediSensors Gains CE Mark Approval for the C8 MediSensors Optical Glucose Monitor(TM) System for People with Diabetes
10. Northwest Bio Receives Regulatory Approval To Proceed With Its Phase III Trial In The UK
11. Perrigo Receives FDA Approval And Commences Launch Of Morphine Sulfate 100ml/5% Oral Solution
Post Your Comments:
(Date:11/25/2015)... , Nov. 25, 2015 /PRNewswire/ - Aeterna Zentaris Inc. ... its business and prospects remain fundamentally strong and ... (zoptarelin doxorubicin) recently received DSMB recommendation to continue ... following review of the final interim efficacy and ... Primary Endpoint in men with heavily pretreated castration- ...
(Date:11/25/2015)... , Nov. 25, 2015 Orexigen® Therapeutics, ... will participate in a fireside chat discussion at the ... New York . The discussion is scheduled for ... .  A replay will be available ... Contact:McDavid Stilwell  , Julie NormartVP, Corporate Communications and ...
(Date:11/25/2015)... ... November 25, 2015 , ... Jessica ... on AngelList early in their initial angel funding process. Now, they are paying ... looking to make early stage investments in the microbiome space. In this, ...
(Date:11/24/2015)... HILLS, N.J. (PRWEB) , ... November 24, 2015 , ... ... as the recipient of the 2016 USGA Green Section Award. Presented annually since 1961, ... golf through his or her work with turfgrass. , Clarke, of Iselin, ...
Breaking Biology Technology:
(Date:11/12/2015)... BOSTON , Nov. 12, 2015  A golden ... for Duchenne muscular dystrophy (DMD) has provided a new ... Boston Children,s Hospital, the Broad Institute of MIT and ... Brazil . Cell, ... some dogs "escape" the disease,s effects. The Boston Children,s ...
(Date:11/10/2015)... YORK , Nov. 10, 2015 ... to behavioral biometrics that helps to identify and ... fraud. Signature is considered as the secure and ... the identification of a particular individual because each ... more accurate results especially when dynamic signature of ...
(Date:10/29/2015)... MINNETONKA, Minn. , Oct. 29, 2015   ... that supports the entire spectrum of clinical research, is ... the Minnesota High Tech Association (MHTA) as one of ... in the "Software – Small and Growing" category. The ... and individuals who have shown superior technology innovation and ...
Breaking Biology News(10 mins):